Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
United Sts Brent Oil Fd Lp Unit
BNO
5
ProShares Ultra Energy
DIG
US Stock MarketDetailed Quotes
Atossa Therapeutics (ATOS)
- 4.820
- -0.060-1.23%
Close Apr 8 16:00 ET
- 4.990
- +0.170+3.53%
Post 20:01 ET
41.51MMarket Cap-1.19P/E (TTM)
5.135High4.730Low76.98KVolume5.080Open4.880Prev Close375.15KTurnover0.89%Turnover RatioLossP/E (Static)8.61MShares19.35052wk High1.05P/B41.49MFloat Cap3.76052wk Low--Dividend TTM8.61MShs Float33479.972Historical High--Div Yield TTM8.30%Range %3.760Historical Low4.873Avg Price1Lot Size
Atossa Therapeutics (ATOS) Key Financial Indicators
ATOS Earnings per Share (EPS)
According to the latest financial report of Atossa Therapeutics, the latest earnings per share (TTM) for the company is -1.34. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
ATOS Free Cash Flow (FCF)
Interested in knowing about Atossa Therapeutics's free cash flow? The latest report shows it as -10.55M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
ATOS Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Atossa Therapeutics shows that the company's current ratio is 5.53, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
ATOS Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Atossa Therapeutics, the quick ratio is 5.00, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ATOS Return on Equity (ROE)
Want to learn more about the financial health of Atossa Therapeutics? The latest ROE figure is -24.54%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ATOS Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Atossa Therapeutics, the total asset return on investment (ROA) is -20.71%.
Currency: USD
Quarterly
Loading...
ATOS Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Atossa Therapeutics's latest financial report to see how their gross margin is doing - currently at 100.00%.
Currency: USD
Quarterly
Loading...
ATOS Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Atossa Therapeutics, the net profit margin is -282.23K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
The US-Iran situation has reached a major turning point as Trump announced a two-week suspension of military actions against Iran, with both
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm